Join 55,000+ subscribers getting smarter about psychedelics in under 10 minutes a week. Research π¬, policy ποΈ, and business π, with a side of spicy memes. π«
I consent to receive newsletters via email. Sign Up Terms of Service.
Tap into our mycelial network.
[5-min read] Q&A with AmaΜnda Efthimiou, Consultant & Coach
[5-min read] FDA and DEA schedule public hearings on psychedelics.
[5-min read] Q&A with Stephanie Karzon Abrams, Neuropharmacologist & Founder
[5-min read] MindBio shares durability data from LSD microdosing study.
[6-min read] Q&A with Carlos Tanner, Curandero & Founder
[5-min read] Rick Doblin steps down from Lykos Therapeutics.
[5-min read] Q&A with Kevin Cannella, Cofounder & Director
[5-min read] FDA rejects Lykos's application for MDMA-assisted therapy.
[5-min read] Q&A with Acacea Lewis, Researcher & Historian
[5-min read] New studies suggest psychedelics could treat diabetes and obesity.
[5-min read] Q&A with Daniel Carcillo, NHL Champion & Entrepreneur
[5-min read] J&J submits Spravato to the FDA for expanded approval.
